Can AI offer disruptive opportunities for pharma?

Can AI offer disruptive opportunities for pharma?

Artificial Intelligence (AI), Big Data, and machine learning have become widespread tools in the business world, particularly for enhancing efficiency in automated manufacturing processes and uncovering patterns within vast datasets.

While it took some time to gain traction, recent research indicates that the healthcare sector worldwide is also embracing AI at an increasing pace. In 2022, investments in AI for healthcare amounted to approximately USD 15 billion, and it is projected to surpass USD 187 billion by 2030.

However, do these growth projections apply uniformly across various markets and regions? We sought insights from our Pharmaceuticals Experts based in the Asia-Pacific, Europe, and the Americas regions regarding the utilization and potential opportunities associated with AI and Big Data in their respective areas.

Learn more here:

Leave a Reply